Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : UPCA - Uniprime Capital Acceptance, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: faro who wrote (261)	7/26/1999 3:39:00 PM
From: faro	Read Replies (3) \| Respond to of 640

News Out!!! It looks like we are in for more than a week or so. I would say weeks, if lucky and probably months or another life! Armand -- =DJ Uniprime CEO Says He Has Been Subpoenaed By SEC -- By Rick Jurgens PHOENIX (Dow Jones)--The top executive of Uniprime Capital Acceptance Inc. (UPCA), which saw its stock soar last week after it made an AIDS treatment claim, said he has been subpoenaed by the Securities and Exchange Commission. Gary Tabb, Uniprime's chief executive, told Dow Jones Newswires he has been ordered to provide documents to the SEC by Wednesday and appear at the SEC office in New York City on Friday. Tabb declined to provide a copy of the subpoena until he consulted with his lawyer. An SEC spokeswoman said that as a matter of policy she could neither confirm nor deny that an investigation of Uniprime was under way. But the SEC suspended trading in Uniprime stock after the market closed Wednesday, and such investigations typically follow trading suspensions. The SEC acted after shares in Uniprime, which was listed on the over-the-counter bulletin board, had shot up to 7 15/16 Tuesday on volume of 5.2 million shares, compared with average volume of 84,000 shares. The previous high of 1 15/32 came in June after an earlier company release on the AIDS treatment. Tabb said the company believes the treatment had "reversed" but not "cured" the HIV virus in AIDS patients. He said he had wired $2,500 to Spain to pay for the reproduction of records of tests of the new treatment. He said when an expected 16-pound shipment of documents arrives at his company's office, he would allow them to be reviewed by "anybody." Tabb said his main focus now is on documenting the identity of Alfred Flores, the researcher who supposedly developed the treatment. "All I'm trying to prove is that the guy is real, he's not phony," Tabb said. "He's not a big medical doctor or nothing like that, but he's real." Flores was not immediately available for comment. - By Rick Jurgens; 602-258-2003; richard.jurgens@cor.dowjones.com (END) DOW JONES NEWS 07-26-99 01:46 PM- - 01 46 PM EDT 07-26-99 Symbols: US;UPCA Source DJ - Dow Jones Categories: G/SEC SUB/DJN N/DJN SUB/DJWI N/DJWI SUB/DJS N/DJS SUB/RGU N/RGU M/NND GEO/NME R/NME GEO/US R/US